قائمة الدراسات السريرية المسجلة على الادوية

عنوان الدراسة	داعم الدراسة	حالة الدراسة	دواء الدراسة	مرحلة الدراسة	رقم بروتوكول الدراسة	موقع الدراسة
Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Arena film-coated tablets (150 mg irbesartan) Produced by Jamjoom/ KSA versus Aprovel® film-coated tablets (150 mg irbesartan) Produced by Sanofi-aventis / Germany, in healthy subjects under fasting condition.	SFDA	Ongoing	Arena	BE	Aug-17	Saudi Ajal
Randomized, three-way, three-period, single oral dose, open-label, crossover, bioequivalence study to compare Lipomax tablets (20 mg atorvastatin) Produced by SAJA / KSA, versus Lipitor® tablets (20 mg atorvastatin) Produced by Pfizer / Ireland, in healthy subjects under fasting conditions.	SFDA	Ongoing	Lipomax	BE	Nov-17	Saudi Ajal
Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Pedovex film-coated tablets (75 mg clopidogrel) Produced by Tabuk / KSA versus Plavix® film-coated tablets (75 mg clopidogrel) Produced by Sanofi-aventis / KSA, in healthy subjects under fasting condition.	SFDA	Ongoing	Pedovex	BE	Oct-17	Saudi Ajal
Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Amlophar Capsules (5 mg amlodipine) Produced by Julphar / UAE versus Amlor® Capsules (5 mg amlodipine) Produced by Pfizer / KSA, in healthy subjects under fasting condition.	SFDA	Ongoing	Amlophar	BE	Dec-17	Saudi Ajal
Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Glymide tablets (5 mg glibenclamide) Produced by Julphar / UAE versus Daonil® tablets (5 mg glibenclamide) Produced Sanofi-Aventis / Germany, in healthy subjects under fed condition.	SFDA	Ongoing	Glymide	BE	13-2017	Saudi Ajal
Randomized, three-way, three-period, single oral dose, open-label, crossover, bioequivalence study to compare Torvacol tablets (20 mg atorvastatin) Produced by JPM / Jordan, versus Lipitor® tablets (20 mg atorvastatin) Produced by Pfizer / Irland in healthy subjects under fasting conditions.	SFDA	Ongoing	Torvacol	BE	15-2017	Saudi Ajal
Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Narapril tablets (20 mg enalapril) Produced by Julphar / UAE versus Renitec® tablets (20 mg enalapril) Produced by Merck Sharp & Dohme / UK, in healthy subjects under fasting condition.	SFDA	Ongoing	Narapril	BE	14-2017	Saudi Ajal
Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Glibil tablets (5 mg glibenclamide) Produced by Hikma / Jordan versus Daonil® tablets (5 mg glibenclamide) Produced Sanofi-Aventis / Germany, in healthy subjects under fed condition.	SFDA	Ongoing	Glibil	BE	17-2017	Saudi Ajal
Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Amlodar Capsules (10 mg amlodipine) Produced by Dar AlDawa / Jordan versus Amlor® Capsules (10 mg amlodipine) Produced by Pfizer / KSA, in healthy subjects under fasting condition.	SFDA	Ongoing	Amlodar	BE	16-2017	Saudi Ajal
"DIREGL07563 RATIONAL studyAn obseRvationAl registry To assess urInary albumin evOlution in Saudi hyperteNsive patients with the current treatment local ALgorithm "	SANOFI	Ongoing	APROVEL / Irbesartan	4	3	King Abdulaziz University Hospital (Jeddah)